Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy

Autor: Yutani, Shigeru, Yamada, Akira, Yoshida, Kazumi, Takao, Yukari, Tamura, Mayumi, Komatsu, Nobukazu, Ide, Tatsuya, Tanaka, Masatoshi, Sata, Michio, Itoh, Kyogo
Zdroj: In Vaccine 2007 25(42):7429-7435
Databáze: ScienceDirect